Business

Sera Prognostics Announces The Appointment Of Sandra A.J. Lawrence To The Sera Prognostics Board

Highly respected healthcare and financial leader joins Sera in its quest to improve pregnancy outcomes of mothers and babies SALT LAKE CITY, Nov. 30, 2021

articleSera Prognostics, Inc.November 30, 20213/company/sera-prognostics-inc/news/sera-prognostics-announces-the-appointment-of-sandra-aj-lawrence-to-the-sera-prognostics-board
Sera Prognostics Announces The Appointment Of Sandra A.J. Lawrence To The Sera Prognostics Board

About this update from Sera Prognostics, Inc.

[{"type":"text","content":"Highly respected healthcare and financial leader joins Sera in its quest to improve pregnancy outcomes of mothers and babies\n\n\nSALT LAKE CITY, Nov. 30, 2021 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that Sandra A. J. Lawrence has joined the Sera Board of Directors. \n\n \n \n \n \n \n \n\n \n\"We are very excited to have Sandra Lawrence join the Sera board,\" said Gregory C. Critchfield, CEO and Chairman of Sera Prognostics. \"Sandra brings to Sera her broad and profound leadership experience having served on multiple public and private boards across a wide array of respected organizations. As an operating officer in C-level executive and financial capacities, she also has relevant first-hand knowledge and perspectives on the challenges and burdens of managing adverse pregnancy outcomes in her service in a major comprehensive pediatric medical center. We are thrilled to have Sandra help us make a meaningful and long-lasting difference in the well-being of all mothers and newborns and help guide the company as we work toward long term durable revenue growth.\"\nMs. Lawrence has served as trustee of the Delaware Funds by Macquarie, as a director of its New York and Australian Stock Exchange-Listed close-end funds, DEW/VCF/DDF/VMM/VFL/IVH, and on its Audit and Investments Committees since 2021. She has served as a trustee of its legacy Ivy and Waddell and Reed Mutual Funds Complex Trust, and on its Governance Committee, since 2019. Ms. Lawrence was the Executive Vice President and Chief Financial Officer of Children's Mercy Hospital, a comprehensive pediatric medical center in Kansas City, Missouri, from 2005 to 2016 and the Executive Vice President and Chief Administrative Officer of Children's Mercy Hospital from 2016 to February 2019. She was Senior Vice President and Treasurer of Midwest Research Institute, an independent, non-profit, contract research organization, located in Kansas City, Missouri, and subsequently its Chief Financial Officer. Ms. Lawrence spent twenty-six years in professional or management positions in the architecture, real estate, investment banking, financial services, packaging, and medical research industries. Ms. Lawren...

More updates from Sera Prognostics, Inc.